iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
190.26
+2.12 (1.13%)
Jul 27, 2026, 10:27 AM EDT - Market open
IBB Holdings Information
IBB is an equity ETF with a total of 252 individual holdings. The top holdings are Amgen stock at 8.11%, Vertex Pharmaceuticals at 7.77%, Gilead Sciences at 7.16%, Regeneron Pharmaceuticals at 5.18%, and argenx SE at 3.78%.
Total Holdings
252
Top 10 Percentage
45.14%
Asset Class
Equity
ETF Category
Health
Assets
9.47B
PE Ratio
23.15
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 8.11% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.77% |
| 3 | GILD | Gilead Sciences, Inc. | 7.16% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.18% |
| 5 | ARGX | argenx SE | 3.78% |
| 6 | NTRA | Natera, Inc. | 2.85% |
| 7 | RVMD | Revolution Medicines, Inc. | 2.83% |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.81% |
| 9 | ILMN | Illumina, Inc. | 2.34% |
| 10 | BIIB | Biogen Inc. | 2.31% |
| 11 | ONC | BeOne Medicines AG | 2.05% |
| 12 | INCY | Incyte Corporation | 1.82% |
| 13 | INSM | Insmed Incorporated | 1.82% |
| 14 | UTHR | United Therapeutics Corporation | 1.71% |
| 15 | MRNA | Moderna, Inc. | 1.63% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.43% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.35% |
| 18 | ASND | Ascendis Pharma A/S | 1.23% |
| 19 | GMAB | Genmab A/S | 1.20% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.10% |
| 21 | MEDP | Medpace Holdings, Inc. | 1.10% |
| 22 | EXEL | Exelixis, Inc. | 1.07% |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.93% |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.90% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.88% |
As of Jul 23, 2026